Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

KIDS vs ESTA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ESTA Captures Overall Composite Edge (25.7 SELL vs 45.1 HOLD), While KIDS Leads 4–2 on Growth & Valuation Pillars

ESTA Overall Winner 6-Pillar Tally: KIDS 4 – 2 ESTA Matrix Metrics: KIDS 4 – 4 ESTA

As of Nov 19, 2026, Establishment Labs Holdings Inc. (ESTA) captures the overall head-to-head institutional edge over OrthoPediatrics Corp. (KIDS) on higher Unified Composite conviction (25.7/100 SELL vs. 45.1/100 HOLD) after splitting the core matrix 4–4 (led by Growth & Scale, Options & Positioning), while KIDS wins 4–2 across the 6-pillar growth and valuation breakdown. KIDS trades at $32.51 (N/M Forward P/E, -8.2% operating margin) versus ESTA at $69.61 (N/M Forward P/E, -6.6% operating margin).

  • Composite vs. Pillar Nuance: While KIDS currently prints a higher short-term Unified Composite Score (45.1/100 HOLD vs. ESTA 25.7/100 SELL), ESTA captures the overall institutional head-to-head verdict (4–4 matrix metrics and 2–4 across the 6 pillars) due to superior fundamental profitability (-6.6% vs. -8.2% operating margin) and revenue trajectory (+33.9% vs. +18.6% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About KIDS vs ESTA
KIDS NASDAQ
OrthoPediatrics Corp. Common Stock
Surgical & Medical Instruments & Apparatus
$32.51
+2.72% 1D
Market Cap $850.2M
TTM Revenue $264M
Forward P/E N/M
Beta / 30D Vol 0.81β · 108% Vol
Unified Composite Score
45.1 / 100 HOLD
Tech 28.0 Fund 40.0 Flow 50.0 Mom 46.3
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (12.1% over 20 days), RSI 64
RSI-14: 64.2 · SMA20: $30.90 · SMA50: $25.86
ESTA NASDAQ Head-to-Head Winner
Establishment Labs Holdings Inc.
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$69.61
-1.68% 1D
Market Cap $2.1B
TTM Revenue $264M
Forward P/E N/M
Beta / 30D Vol 1.55β · 57% Vol
Unified Composite Score
25.7 / 100 SELL
Tech 8.0 Fund 29.0 Flow 56.0 Mom 21.4
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 56
RSI-14: 55.5 · SMA20: $67.14 · SMA50: $65.72

6-Pillar Scorecard Institutional Category Breakdown (KIDS 4 – 2 ESTA)

Columns: Metric · KIDS · ESTA
1. Valuation Multiples KIDS
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 3.2x 8.7x
2. Growth & Scale ESTA
Revenue Growth (YoY) +18.6% +33.9%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $264M $264M
Market Cap $850.2M $2.1B
3. Profitability & Quality KIDS
Gross Margin 73.8% 70.2%
Operating Margin -8.2% -6.6%
Net Profit Margin -12.8% -14.6%
Return on Equity (ROE) -9.8% -240.7%
4. Balance Sheet & Cash Flow KIDS
Cash Generation (TTM) $1.1M EBITDA -$23M
Cash Flow Margin 0.4% EBITDA Mgn -8.8%
Net Cash / Leverage $12.99 Book/Sh · -9.8% ROE $194M Net Debt (17.28x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ESTA
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile 145.1% (100th %ile) 90.4% (12th %ile)
Put/Call OI Skew N/A 0.02x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markup DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat KIDS
OpEx & R&D Intensity 82.0% of Rev ($217M) 76.8% of Rev ($203M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Devices Operator Medical Devices Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: KIDS (4) vs ESTA (4)
Institutional Metric KIDS ESTA Criterion Row Edge
Market Capitalization
Scale
$850.2M $2.1B Larger Scale ESTA
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+18.6% +33.9% Higher Growth ESTA
Operating Margin (TTM)
Profitability
-8.2% -6.6% Higher Margin ESTA
Net Profit Margin
Profitability
-12.8% -14.6% Higher Margin KIDS
Return on Equity (ROE)
Capital Efficiency
-9.8% -240.7% Higher ROE KIDS
52-Week Range Position
Momentum
90% ($14–$35) 37% ($53–$98) Stronger Trend KIDS
Beta / 30D Volatility
Risk Regime
0.81β · 108% Vol 1.55β · 57% Vol Lower Realized Risk ESTA
Unified Institutional Score
Composite Signal
45.1 / 100 (HOLD) 25.7 / 100 (SELL) Higher Composite KIDS
Trailing 12M Revenue (USD)
Operating Scale
$264M $264M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
73.8% 70.2% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 3.2x EV/Rev N/M PEG · 8.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$1.1M EBITDA ($12.99 Book/Sh · -9.8% ROE) -$23M ($194M Net Debt (17.28x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon KIDS +24.6 pp
KIDS: +36.37% · ESTA: +11.77%
3M Horizon KIDS +30.95 pp
KIDS: +26.74% · ESTA: -4.21%
6M Horizon KIDS +78.67 pp
KIDS: +76.4% · ESTA: -2.27%
1Y Horizon KIDS +91.03 pp
KIDS: +98.84% · ESTA: +7.81%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KIDS vs ESTA. Trailing 12-month operating profitability (KIDS -8.2% vs ESTA -6.6%) and valuation multiples (KIDS N/M vs ESTA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

KIDS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$264M
Gross Margin73.8%
Op. Margin-8.2%
ROE / Fwd P/E-9.8% · N/M
ESTA ADR TTM Benchmark FX-Normalized USD
TTM Revenue$264M
Gross Margin70.2%
Op. Margin-6.6%
ROE / Fwd P/E-240.7% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
KIDS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 145.1%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact KIDS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ESTA CONSOLIDATION
104d in phase · OBV DISTRIBUTION
Current IV 90.4%
IV Percentile 12th %ile
Put/Call OI Skew 0.02x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact ESTA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
KIDS Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $850.2M market capitalization and -8.2% operating margin.
OpEx & R&D Reinvestment 82.0% of Rev ($217M)
90D Engineering Disclosures 0 Published
ESTA Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $2.1B market capitalization and -6.6% operating margin.
OpEx & R&D Reinvestment 76.8% of Rev ($203M)
90D Engineering Disclosures 0 Published

Investor FAQ KIDS vs ESTA Key Questions & Quantitative Answers

As of Nov 19, 2026, Establishment Labs Holdings Inc. (ESTA) captures the overall head-to-head institutional edge over OrthoPediatrics Corp. (KIDS) on higher Unified Composite conviction (25.7/100 SELL vs. 45.1/100 HOLD) after splitting the core matrix 4–4 (led by Growth & Scale, Options & Positioning), while KIDS wins 4–2 across the 6-pillar growth and valuation breakdown. KIDS trades at $32.51 (N/M Forward P/E, -8.2% operating margin) versus ESTA at $69.61 (N/M Forward P/E, -6.6% operating margin). Composite vs. Pillar Nuance: While KIDS currently prints a higher short-term Unified Composite Score (45.1/100 HOLD vs. ESTA 25.7/100 SELL), ESTA captures the overall institutional head-to-head verdict (4–4 matrix metrics and 2–4 across the 6 pillars) due to superior fundamental profitability (-6.6% vs. -8.2% operating margin) and revenue trajectory (+33.9% vs. +18.6% YoY).

ESTA leads the Growth & Scale pillar: KIDS posts +18.6% YoY revenue growth and +0.0% YoY earnings growth on $264M TTM revenue (73.8% gross margin, -8.2% operating margin), compared with ESTA at +33.9% YoY revenue growth and +0.0% YoY earnings growth on $264M TTM revenue (70.2% gross margin, -6.6% operating margin). On trailing 12-month operating scale, KIDS generates $264M in USD-normalized revenue versus $264M for ESTA. In operating R&D and SG&A reinvestment, KIDS deploys 82.0% of Rev ($217M) (0 90-day corporate R&D disclosures) versus 76.8% of Rev ($203M) (0 disclosures) for ESTA.

KIDS screens cheaper on headline valuation multiples. KIDS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 3.2x EV/Revenue (0.4% EBITDA margin), whereas ESTA trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 8.7x EV/Revenue (-8.8% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against KIDS (-9.8% ROE) versus ESTA (-240.7% ROE) capital efficiency.

In options market volatility and institutional positioning, KIDS carries 145.1% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.81β · 108% Vol realized risk). By comparison, ESTA carries 90.4% implied volatility (12th %ile, Compressed (<25th %ile)), a 0.02x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.55β · 57% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.